Nuvalent Inc vs iShares Silver Trust — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while iShares Silver Trust trades at $53.2. The key difference: Nuvalent Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| NUVL | SLV | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | — |
52-Week High | $123.96 | $105.57 |
52-Week Low | $72.16 | $33.32 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →